Articles dans des revues avec comité de lecture (191)
  1. 13. Tomasi, L., Thiriard, A., Heyndrickx, L., Georges, D., Van den Wijngaert, S., Olislagers, V., Sharma, S., Matagne, A., Ackerman, M. M., Ariën, K. K., Goetghebuer, T., & Marchant, A. (2022). Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection. Open Forum Infectious Diseases, 9(11), ofac554. doi:10.1093/ofid/ofac554
  2. 14. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  3. 15. Bharadwaj, P., Shrestha, S., Pongracz, T., Concetta, C., Sharma, S., Le Moine, A., de Haan, N., Murakami, N., Riella, L. L., Holovska, V., Wuhrer, M., Marchant, A., & Ackerman, M. M. (2022). Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. Cell reports. Medicine, 3(11), 100818. doi:10.1016/j.xcrm.2022.100818
  4. 16. Strandmark, J., Darboe, A., Diray-Arce, J., Ben-Othman, R., Vignolo, S. S., Rao, S., Smolen, K., Leroux-Roels, G., Idoko, O. T., Sanchez-Schmitz, G., Ozonoff, A., Levy, O., Kollmann, T. R., Marchant, A., & Kampmann, B. (2022). A single birth dose of Hepatitis B vaccine induces polyfunctional CD4+ T helper cells. Frontiers in immunology, 13, 1043375. doi:10.3389/fimmu.2022.1043375
  5. 17. Taylor, S. A., Sharma, S., Remmel, C. C., Holder, B., Jones, C. E., Marchant, A., & Ackerman, M. M. (2022). HIV-Associated Alterations of the Biophysical Features of Maternal Antibodies Correlate With Their Reduced Transfer Across the Placenta. The Journal of infectious diseases, 226(8), 1441-1450. doi:10.1093/infdis/jiac222
  6. 18. Pannus, P., Neven, K., De Craeye, S., Heyndrickx, L., Vande Kerckhove, S., Georges, D., Michiels, J., Francotte, A., Van den Bulcke, M. M., Zrein, M., Gucht, S. V., Schmickler, M.-N., Verbrugghe, M., Matagne, A., Thomas, I., Dierick, K., Martens Weiner, J. E., Ackerman, M. M., Goriely, S., Goossens, M. M., Ariën, K., Desombere, I., & Marchant, A. (2022). Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes. Clinical infectious diseases, 75(1), e695-e704. doi:10.1093/cid/ciab998
  7. 19. Van Elslande, J., Marchant, A., Henin, C., Haerlingen, B., De Mendonça, R., Delforge, M.-L., et al. (2022). Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in A Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine. Viruses, 14(6), 1198. doi:10.3390/v14061198
  8. 20. Brauns, E., Azouz, A., Grimaldi, D., Xiao, H., Thomas, S., Nguyen, M., Olislagers, V., Vu Duc, I., Orte Cano, C., Del Marmol, V., Pannus, P., Libert, F., Saussez, S., Dauby, N., Das, J., Marchant, A., & Goriely, S. (2022). Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI insight, 7(9). doi:10.1172/jci.insight.154183
  9. 21. Baron, F., Canti, L., Ariën, K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., Beguin, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in immunology, 13, 827242. doi:10.3389/fimmu.2022.827242
  10. 22. Crowley, A. A., Natarajan, H., Hederman, A. A., Bobak, C. C., Weiner, J. J., Wieland-Alter, W., Lee, J., Bloch, E. E., Tobian, A. A., Redd, A. A., Blankson, J. J., Wolf, D., Goetghebuer, T., Marchant, A., Connor, R. R., Wright, P. P., & Ackerman, M. M. (2022). Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike. eLife, 11. doi:10.7554/eLife.75228
  11. 23. Pannus, P., Depickère, S., Kemlin, D., Houben, S., Neven, K. Y., Heyndrickx, L., Michiels, J., Willems, E., De Craeye, S., Francotte, A., Chaumont, F., Olislagers, V., Waegemans, A., Verbrugghe, M., Schmickler, M.-N., Van Gucht, S., Dierick, K., Marchant, A., Desombere, I., Ariën, K. K., & Goossens, M. M. (2022). Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. PLOS global public health, 2(12), e0001308. doi:10.1371/journal.pgph.0001308
  12. 24. Budroni, S., Buricchi, F., Cavallone, A., Bourguignon, P., Caubet, M., Dewar, V., D’Oro, U., Finco, O., Garçon, N., El Idrissi, M., Janssens, M., Leroux-Roels, G., Marchant, A., Schwarz, T. F., Van Damme, P., Volpini, G., van der Most, R., Didierlaurent, A. M., & Burny, W. (2021). Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. NPJ vaccines, 6(1), 78. doi:10.1038/s41541-021-00337-0
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>